A phase 2 dose-finding trial in subjects with type 2 diabetes showed clear dose-dependent effects on HbA1c and weight over 12 weeks of treatment
Obstructive Sleep Apnea (OSA): In December 2024, the FDA approved Zepbound for improving snoring in obese patients with moderate to severe OSA, making it the first and only prescription medication approved for this sleep disorder
These updates to the health history forms will help our dental community create more compassionate environments for care and enable greater coordination with physicians and mental health professionals for whole-body health. To support dental professionals in addressing mental health concerns, the ADA hosted a live webinar in January titled The Dental Visit: Bridging Patients to Mental Healthcare Through Connection, which was moderated by Jennifer Thompson, D.D.S., chair of the ADA Council on Dental Practice
You can read the full article at Tesofensine is a new drug that has been shown to be more effective in promoting weight loss compared to currently available drugs
More interestingly, exendin-4 treatment upregulated adiponectin levels in high fat diet-fed mice to a level significantly higher than mice fed with normal diet (Fig 4)
Trust us, we extensively researched and tested this injectable before offering semaglutide in Franklin